search
Back to results

Defocused Shock Wave Therapy for Chronic Wounds

Primary Purpose

Wounds

Status
Completed
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
Defocused shock wave therapy (DUOLITH® SD1)
Sponsored by
University of Roma La Sapienza
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wounds focused on measuring Shock waves

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • chronic post-traumatic, venous, arterial, diabetic, or mixed wound of the lower limb
  • wound persisting for longer than three months
  • a wound surface bigger than 0,5 cm2
  • a wound diameter between 0.5 and 5 cm
  • unresponsiveness to conservative treatments and advanced wound managements in the 3 months prior to enrollment
  • no changes in wound managements during the study.

Exclusion Criteria:

  • an ankle brachial index (ABPI)<0.7 and TcPO2<40 mmHg
  • arrhythmias, presence of pacemaker, or coagulation disorders
  • use of anticoagulant drugs
  • neoplasia
  • pregnancy
  • soft tissue wound infections and/or osteomyelitis
  • patients with full-thickness loss of soft tissue and extension into muscle, bone, tendon, or joint capsule.

Sites / Locations

  • Sant'Andrea Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment Group

Arm Description

Defocused shock waves were provided by an electromagnetic generator (DUOLITH® SD1 - Storz Medical AG, Tägerwilen, Switzerland). The protocol consisted of a series of 3 sessions in 2 weeks, 2 treatments a week. For each patient, a different number of impulses per session was delivered, depending on wound size (300 impulses + 100 impulses per cm2 wound-surface), at an energy flux density of 0.15 mJ/mm2 and a frequency of 5 pulses/s.

Outcomes

Primary Outcome Measures

Changes from baseline of the wound surface
Computerized digital photo documentation was used to define the size of the wound with a specific software

Secondary Outcome Measures

Changes from baseline of the wound characteristic
Wounds characteristics were assessed by the Bates-Jensen Wound Assessment Tool
Improvement in subjective wound-related pain intensity
Subjective wound-related pain was evaluated using the Visual Analogue Score

Full Information

First Posted
March 27, 2015
Last Updated
April 6, 2015
Sponsor
University of Roma La Sapienza
search

1. Study Identification

Unique Protocol Identification Number
NCT02410447
Brief Title
Defocused Shock Wave Therapy for Chronic Wounds
Official Title
Defocused Shock Wave Therapy for Chronic Soft Tissue Wounds of the Lower Limbs. A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2015
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
February 2015 (Actual)
Study Completion Date
March 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Roma La Sapienza

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Chronic soft tissue wounds of the lower limbs are painful and debilitating condition that significantly reduce the quality of life of the patient. They often do not respond to conservative treatments or advanced wound managements. Focused and defocused extracorporeal shock wave therapy can be a viable alternative therapeutic strategy. The purpose of the study was to examine the effects of defocused extracorporeal shock wave treatment on chronic soft tissue wounds of the lower limbs, in terms of the rate of wound healing and pain control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wounds
Keywords
Shock waves

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment Group
Arm Type
Experimental
Arm Description
Defocused shock waves were provided by an electromagnetic generator (DUOLITH® SD1 - Storz Medical AG, Tägerwilen, Switzerland). The protocol consisted of a series of 3 sessions in 2 weeks, 2 treatments a week. For each patient, a different number of impulses per session was delivered, depending on wound size (300 impulses + 100 impulses per cm2 wound-surface), at an energy flux density of 0.15 mJ/mm2 and a frequency of 5 pulses/s.
Intervention Type
Device
Intervention Name(s)
Defocused shock wave therapy (DUOLITH® SD1)
Primary Outcome Measure Information:
Title
Changes from baseline of the wound surface
Description
Computerized digital photo documentation was used to define the size of the wound with a specific software
Time Frame
15 days, 1 month and 3 months after treatment
Secondary Outcome Measure Information:
Title
Changes from baseline of the wound characteristic
Description
Wounds characteristics were assessed by the Bates-Jensen Wound Assessment Tool
Time Frame
15 days, 1 month and 3 months after treatment
Title
Improvement in subjective wound-related pain intensity
Description
Subjective wound-related pain was evaluated using the Visual Analogue Score
Time Frame
15 days, 1 month and 3 months after treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: chronic post-traumatic, venous, arterial, diabetic, or mixed wound of the lower limb wound persisting for longer than three months a wound surface bigger than 0,5 cm2 a wound diameter between 0.5 and 5 cm unresponsiveness to conservative treatments and advanced wound managements in the 3 months prior to enrollment no changes in wound managements during the study. Exclusion Criteria: an ankle brachial index (ABPI)<0.7 and TcPO2<40 mmHg arrhythmias, presence of pacemaker, or coagulation disorders use of anticoagulant drugs neoplasia pregnancy soft tissue wound infections and/or osteomyelitis patients with full-thickness loss of soft tissue and extension into muscle, bone, tendon, or joint capsule.
Facility Information:
Facility Name
Sant'Andrea Hospital
City
Rome
ZIP/Postal Code
00144
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
17904157
Citation
Schaden W, Thiele R, Kolpl C, Pusch M, Nissan A, Attinger CE, Maniscalco-Theberge ME, Peoples GE, Elster EA, Stojadinovic A. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res. 2007 Nov;143(1):1-12. doi: 10.1016/j.jss.2007.01.009. Epub 2007 Sep 27.
Results Reference
background
PubMed Identifier
18394777
Citation
Saggini R, Figus A, Troccola A, Cocco V, Saggini A, Scuderi N. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol. 2008 Aug;34(8):1261-71. doi: 10.1016/j.ultrasmedbio.2008.01.010. Epub 2008 Apr 18.
Results Reference
background
PubMed Identifier
19473538
Citation
Moretti B, Notarnicola A, Maggio G, Moretti L, Pascone M, Tafuri S, Patella V. The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord. 2009 May 27;10:54. doi: 10.1186/1471-2474-10-54.
Results Reference
background
PubMed Identifier
20071091
Citation
Arno A, Garcia O, Hernan I, Sancho J, Acosta A, Barret JP. Extracorporeal shock waves, a new non-surgical method to treat severe burns. Burns. 2010 Sep;36(6):844-9. doi: 10.1016/j.burns.2009.11.012. Epub 2010 Jan 13.
Results Reference
background
PubMed Identifier
22642362
Citation
Mittermayr R, Antonic V, Hartinger J, Kaufmann H, Redl H, Teot L, Stojadinovic A, Schaden W. Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen. 2012 Jul-Aug;20(4):456-65. doi: 10.1111/j.1524-475X.2012.00796.x. Epub 2012 May 29.
Results Reference
background
PubMed Identifier
2359293
Citation
Haupt G, Chvapil M. Effect of shock waves on the healing of partial-thickness wounds in piglets. J Surg Res. 1990 Jul;49(1):45-8. doi: 10.1016/0022-4804(90)90109-f.
Results Reference
background
PubMed Identifier
19152654
Citation
Kuo YR, Wang CT, Wang FS, Yang KD, Chiang YC, Wang CJ. Extracorporeal shock wave treatment modulates skin fibroblast recruitment and leukocyte infiltration for enhancing extended skin-flap survival. Wound Repair Regen. 2009 Jan-Feb;17(1):80-7. doi: 10.1111/j.1524-475X.2008.00444.x.
Results Reference
background
PubMed Identifier
21310502
Citation
Wang CJ, Wu RW, Yang YJ. Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Res Clin Pract. 2011 May;92(2):187-93. doi: 10.1016/j.diabres.2011.01.019. Epub 2011 Apr 6.
Results Reference
background
PubMed Identifier
15740982
Citation
Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, Russo S, Suzuki H. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide. 2005 Mar;12(2):89-96. doi: 10.1016/j.niox.2004.12.005.
Results Reference
background
PubMed Identifier
11711214
Citation
Ohtori S, Inoue G, Mannoji C, Saisu T, Takahashi K, Mitsuhashi S, Wada Y, Takahashi K, Yamagata M, Moriya H. Shock wave application to rat skin induces degeneration and reinnervation of sensory nerve fibres. Neurosci Lett. 2001 Nov 23;315(1-2):57-60. doi: 10.1016/s0304-3940(01)02320-5.
Results Reference
background
PubMed Identifier
19614917
Citation
Kuo YR, Wang CT, Wang FS, Chiang YC, Wang CJ. Extracorporeal shock-wave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in a rat model of STZ-induced diabetes. Wound Repair Regen. 2009 Jul-Aug;17(4):522-30. doi: 10.1111/j.1524-475X.2009.00504.x.
Results Reference
background
PubMed Identifier
23110611
Citation
Hayashi D, Kawakami K, Ito K, Ishii K, Tanno H, Imai Y, Kanno E, Maruyama R, Shimokawa H, Tachi M. Low-energy extracorporeal shock wave therapy enhances skin wound healing in diabetic mice: a critical role of endothelial nitric oxide synthase. Wound Repair Regen. 2012 Nov-Dec;20(6):887-95. doi: 10.1111/j.1524-475X.2012.00851.x. Epub 2012 Oct 30.
Results Reference
background
PubMed Identifier
20156981
Citation
Larking AM, Duport S, Clinton M, Hardy M, Andrews K. Randomized control of extracorporeal shock wave therapy versus placebo for chronic decubitus ulceration. Clin Rehabil. 2010 Mar;24(3):222-9. doi: 10.1177/0269215509346083. Epub 2010 Feb 15.
Results Reference
background
PubMed Identifier
23322179
Citation
Stieger M, Schmid JP, Bajrami S, Hunziker T. [Extracorporeal shock wave therapy as a treatment of a non-healing chronic leg ulcer]. Hautarzt. 2013 Jun;64(6):443-6. doi: 10.1007/s00105-012-2527-4. German.
Results Reference
background
PubMed Identifier
25451894
Citation
Omar MT, Alghadir A, Al-Wahhabi KK, Al-Askar AB. Efficacy of shock wave therapy on chronic diabetic foot ulcer: a single-blinded randomized controlled clinical trial. Diabetes Res Clin Pract. 2014 Dec;106(3):548-54. doi: 10.1016/j.diabres.2014.09.024. Epub 2014 Oct 5.
Results Reference
background
PubMed Identifier
21640475
Citation
Wolff KS, Wibmer A, Pusch M, Prusa AM, Pretterklieber M, Teufelsbauer H, Schaden W. The influence of comorbidities and etiologies on the success of extracorporeal shock wave therapy for chronic soft tissue wounds: midterm results. Ultrasound Med Biol. 2011 Jul;37(7):1111-9. doi: 10.1016/j.ultrasmedbio.2011.04.007. Epub 2011 Jun 2.
Results Reference
background
PubMed Identifier
18619622
Citation
Wang CJ, Kuo YR, Wu RW, Liu RT, Hsu CS, Wang FS, Yang KD. Extracorporeal shockwave treatment for chronic diabetic foot ulcers. J Surg Res. 2009 Mar;152(1):96-103. doi: 10.1016/j.jss.2008.01.026. Epub 2008 Mar 7.
Results Reference
background

Learn more about this trial

Defocused Shock Wave Therapy for Chronic Wounds

We'll reach out to this number within 24 hrs